Lantus

op-selling drugs might be first in line for Medicare price negotiations
Fierce Pharma
Wed, 09/23/15 - 09:50 pm
Medicare
drug pricing
Hillary Clinton
GSK
Advair
AstraZeneca
Crestor
Merck
Januvia
Sanofi
Lantus
Celgene
Revlimid
Lilly, Boehringer amp up fight against Lantus with U.K. biosim launch
Fierce Pharma
Sat, 08/29/15 - 08:57 am
Lantus
Eli Lilly
biosimilars
diabetes
Boehringer Ingelheim
Sanofi
Stalwart brands from AZ, Glaxo and Sanofi top ranks of most-prescribed meds
Fierce Pharma
Mon, 08/17/15 - 11:41 am
AstraZeneca
GSK
Sanofi
Advair
Crestor
Lantus
Nexium
Vyvanse
Sanofi, Gilead get boosts in Japan with new Lantus & Harvoni approvals
BioPharma Dive
Tue, 07/7/15 - 10:51 am
Sanofi
Gilead Sciences
Japan
Lantus
Harvoni
diabetes
hepatitis C
Lilly says peglispro is superior to Sanofi's Lantus
Medical Marketing and Media
Mon, 06/8/15 - 10:02 pm
Eli Lilly
Peglispro
basal insulin
Sanofi
Lantus
diabetes
insulin
Novo Nordisk type 2 diabetes combo drug tops Sanofi's Lantus -study
Yahoo/Reuters
Sun, 06/7/15 - 10:03 am
Novo Nordisk
type 2 diabetes
Sanofi
IDegLira
Lantus
Lucky 7 diabetes meds to join blockbuster club by 2020
Fierce Pharma Marketing
Tue, 05/12/15 - 04:27 pm
diabetes
Sanofi
Lantus
Merck
Januvia
Eli Lilly
Humalog
Novo Nordisk
Xultophy
Tresiba
Diabetes Drugs Compete With Prices That Rise in Lockstep
Yahoo/Bloomberg
Wed, 05/6/15 - 10:04 am
diabetes
drug pricing
Lantus
Levemir
Sanofi digs in heels, won't discount Lantus insulin successor Toujeo
BioPharma Dive
Mon, 04/13/15 - 10:30 am
Sanofi
insulin
diabetes
Toujeo
Lantus
Novo Nordisk's Tresiba news a black cloud for Sanofi's new CEO
Fierce Pharma
Fri, 03/27/15 - 09:44 pm
Novo Nordisk
Tresiba
Sanofi
Lantus
Olivier Brandicourt
Sanofi's new Lantus may not be the new Lantus
Medical Marketing and Media
Thu, 02/26/15 - 10:30 pm
Sanofi
diabetes
Toujeo
Lantus
FDA OKs Sanofi's Toujeo. Will a diabetes drug price war follow?
Fierce Biotech
Thu, 02/26/15 - 10:00 am
Sanofi
diabetes
Toujeo
drug pricing
Lantus
Tresiba
Novo Nordisk
Lilly peglispro delay may be boon for its biosimilar
Medical Marketing and Media
Mon, 02/23/15 - 05:54 pm
Eli Lilly
Peglispro
diabetes
basal insulin
biosimilars
Sanofi
Lantus
FirstWord Lists – The best selling drugs in 2014
First Word Pharma
Mon, 02/16/15 - 04:50 pm
Humira
Sovaldi
Remicade
Enbrel
Lantus
Rituxan
Advair
Avastin
Herceptin
Januvia
Merck
AbbVie
Gilead Sciences
JNJ
Amgen
Pfizer
Sanofi
Roche
GSK
The top 10 patent losses of 2015
Fierce Pharma
Fri, 12/19/14 - 08:35 am
patents
Lantus
Abilify
Copaxone
Neulasta
Tracleer
Namenda
Avodart
Jalyn
Zyvox
Androgel
Synagis
Sanofi
Bristol-Myers Squibb
Otsuka
Teva Pharmaceutical
Amgen
Actelion
Actavis
GSK
Pfizer
AbbVie
AstraZeneca
Digesting Sanofi's Two Pieces Of News- Lantus' Challenging Outlook And The CEO Dismissal
Seeking Alpha
Wed, 11/5/14 - 08:11 am
Sanofi
Lantus
Chris Viehbacher
Sanofi shares plunge after diabetes drug warning
Yahoo/AP
Tue, 10/28/14 - 08:57 am
Sanofi
diabetes
Lantus
Sanofi And Novo Nordisk‘s Basal-Insulin Battle Continues
Bidness Etc.
Mon, 10/6/14 - 11:51 am
Sanofi
Novo Nordisk
basal insulin
diabetes
Lantus
Levemir
Sanofi Still Ahead Of Novo Nordisk In Insulin Drug Race
Bidness Etc.
Wed, 09/17/14 - 04:53 pm
Sanofi
Novo Nordisk
diabetes
insulin
Lantus
Tresiba
Toujeo
Who's Winning The Insulin Showdown?
Bidness Etc.
Tue, 09/9/14 - 10:33 am
insulin
diabetes
Eli Lilly
Sanofi
Lantus
Peglispro

Pages